Must historians exclude claims about miracles?
Moving beyond COVID crazy: Is there evidence for Jesus’s resurrection?
Why Do Democrats Seem Bent on Making this Worse?
I have never been an advocate of conspiracy theories, because they violate the rule of parsimony known as Occam’s Razor — loosely, “the simplest explanation that accounts for all of the data should be preferred.” Too often conspiracy mavens advance “enormously complex coordinated malfeasance” as an explanation for that which is far more easily explained by simple stupidity. Take the 2008 fiscal crisis as an example. There is no need to invoke a vast government conspiracy to explain it. The crisis had its roots in the cratering of the subprime mortgage industry, which in turn was caused by the government dictating lending policies to achieve goals the government deemed more important than sound lending practices. Stupid? Of course. Nefarious? Probably Read More ›
Revisit: Unified theory of evolution, 2016
On Scientific Methods and alternatives to the “Placebo Control is the gold standard” view, in the face of pandemics (–> Logic & First Principles, 38)
It is clear that we need to re-think how we go about doing science to warrant approaches to the pandemic. So, allow me to headline a comment from the double-blind thread: KF, 16: >> I am also thinking back to the old “Scientific Method” summary we were taught in schools and its roots in Newton’s Opticks, Query 31: As in Mathematicks, so in Natural Philosophy, the Investigation of difficult Things by the Method of Analysis, ought ever to precede the Method of Composition. This Analysis consists in making Experiments and Observations, and in drawing general Conclusions from them by Induction, and admitting of no Objections against the Conclusions, but such as are taken from Experiments, or other certain Truths. For Read More ›
Larry Moran’s uphill battle convincing scientists that most of the genome is junk DNA
Classic “evolution” rubbish about COVID-19
BREAKING: Stanford Study: COVID-19 Case Fatality Rate May be Overstated by a factor of 85
As we have discussed in these pages, the CFR (case fatality rate) for COVID-19 is extremely difficult to calculate. We have a rough estimate of the numerator (deaths). But even that may be off, because of the difference between dying “with” COVID-19 and dying “of” COVID-19. In other words, if a person who was going to die of cancer today anyway gets COVID-19 an hour before he dies, is it correct to say he died of the virus just because he had it when he died. This is not theoretical. The Health Minister of Italy said the virus fatality number in his country is certainly overstated for this reason. For all the problems the numerator has, they pale in comparison Read More ›
Time to End One-Size-Fits-All Virus Response
Trump’s plan calls for protecting vulnerable age cohorts while letting the less vulnerable get back to work. The two charts below demonstrate why opposition to this proposal borders on the insane. The first chart is from CDC’s website showing COVID-19 deaths by age cohort as of April 17. The total is only 13,130, because CDC is behind in sorting this data. According to Worldmeter, total US deaths as of April 17 are 37,230. The second chart assumes the rates stay the same as the data is compiled (and I see no reason we should not assume that). Then I calculate total deaths as of today by age cohort. One number should jump out at you. 3,315. That is the total number Read More ›
H’mm, Remdesivir may be promising . . .
I am seeing a report: Gilead Science’s experimental antiviral medicine remdesivir is reportedly showing promise for the treatment of people plagued with the novel coronavirus, with nearly all patients in a closely monitored clinical trial at a Chicago hospital discharged in just days, an early assessment of data released this week revealed . . . . STAT, a medical news outlet, first reported that an early peek at the data from the clinical trial in Chicago suggested that coronavirus patients were responding to the Gilead Science drug. “The best news is that most of our patients have already been discharged, which is great. We’ve only had two patients perish,” Kathleen Mullane, the University of Chicago infectious disease specialist overseeing the Read More ›
Guardian exemplifies the placebo control gold standard fallacy (–> being, Logic and First Principles, 37)
Shortly after I posted yesterday on whether placebo based studies are properly a gold standard, one of our common objectors, JT, linked the Guardian. Perhaps, he did not realise just how aptly it illustrates my point. I therefore responded, as I now headline as a shop window case- in- point illustration of what is going wrong with medical testing, linked statistics and linked ethics . . . not to mention, too much of the media and the way we tend to think: This is part of why I have written as I have in the OP: [Guardian, annotated:] >>The French doctor Didier Raoult has claimed [–> has reported, on now almost 3,000 patients, under a test protocol approved by relevant Read More ›